Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by rustycaton Aug 14, 2017 2:54pm
209 Views
Post# 26579572

Share weakness

Share weaknessI guess a number of the 5.8 million shares that were purchased 4 months ago @.70 are starting to hit the market.  Obviously, it's a losing trade unless one considers the Purchaser can retain the Warrant which will allow the purchase of one share for the next 1.3 years (about, anyway) for $1.00.
With the low trading vol. at present, I have to wonder how much the Market is willing to absorb without taking the price down to the point of stupid-ness for Sellers that are committed.  
Guess we'll see.
OTOH, it may be just be Market fatigue, but the lack of Buyers seems to point to folks sitting on the sidelines waiting to see how low it will go.
And, when we see some positive announcements those shares will certainly muffle upward movement and will be sold into any bounce.
Bullboard Posts